Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkić(Ghent University), Roosmarijn E. Vandenbroucke(VIB-UGent Center for Inflammation Research), Bart De Strooper(VIB-KU Leuven Center for Brain & Disease Research), Elien Van Wonterghem(Ghent University), Nina Gorlé(Ghent University), Selma Kanazir(University of Belgrade), Iryna Benilova(VIB-KU Leuven Center for Cancer Biology), Claude Libert(VIB-UGent Center for Inflammation Research), Inge Van Hove(KU Leuven), Lieve Moons(Allen Institute for Brain Science), Sriram Balusu(Ghent University)
Cited by 181
Related Papers
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
Is there new hope for therapeutic matrix metalloproteinase inhibition?
|Nature Reviews Drug Discovery|2014|814
A General Introduction to Glucocorticoid Biology
|Frontiers in Immunology|2019|588